Adamis Pharmaceuticals Corp (ADMP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Adamis Pharmaceuticals Corp (ADMP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7853
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. It also offers pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-4000 for the treatment of asthma and chronic obstructive pulmonary disease; and steroid product for the treatment of allergic rhinitis. The company has operations in Phoenix and San Diego. Adamis is headquartered in San Diego, California, the US.

Adamis Pharmaceuticals Corp (ADMP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Adamis Pharmaceuticals Corp, Medical Equipment, Deal Details 10
Partnerships 10
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 10
Adamis Pharma Enters into Distribution Agreement with Sandoz 11
Equity Offering 12
Adamis Pharma Rises USD40.2 Million in Public Offering of Shares 12
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 13
Adamis Pharma Raises USD11 Million in Private Placement of Units 15
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 18
Adamis Pharmaceuticals Corp – Key Competitors 19
Adamis Pharmaceuticals Corp – Key Employees 20
Adamis Pharmaceuticals Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 10, 2018: Adamis Pharmaceuticals announces second quarter 2018 financial results and business update 22
May 10, 2018: Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update 24
Other Significant Developments 25
Mar 15, 2018: Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Adamis Pharmaceuticals Corp, Medical Equipment, Key Facts, 2017 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Deals By Market, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 10
Adamis Pharma Enters into Distribution Agreement with Sandoz 11
Adamis Pharma Rises USD40.2 Million in Public Offering of Shares 12
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 13
Adamis Pharma Raises USD11 Million in Private Placement of Units 15
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 18
Adamis Pharmaceuticals Corp, Key Competitors 19
Adamis Pharmaceuticals Corp, Key Employees 20
Adamis Pharmaceuticals Corp, Subsidiaries 21

List of Figures
Adamis Pharmaceuticals Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Adamis Pharmaceuticals Corp (ADMP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thin Film Electronics ASA (THIN):企業の財務・戦略的SWOT分析
    Thin Film Electronics ASA (THIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hooters of America, LLC :企業の戦略・SWOT・財務情報
    Hooters of America, LLC - Strategy, SWOT and Corporate Finance Report Summary Hooters of America, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Burns & McDonnell:企業の戦略・SWOT・財務情報
    Burns & McDonnell - Strategy, SWOT and Corporate Finance Report Summary Burns & McDonnell - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Epigenomics AG (ECX):医療機器:M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • La Francaise Des Jeux SA:企業の戦略的SWOT分析
    La Francaise Des Jeux SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Mission Pharmacal Company-製薬・医療分野:企業M&A・提携分析
    Summary Mission Pharmacal Company (Mission Pharmacal) is a pharmaceutical company, which develops, manufactures and markets prescription, over-the-counter, and dietary supplement products. It offers products for conditions related to women’s health, urology, pediatrics, and dermatology, among others …
  • Bank Rossiya
    Bank Rossiya - Strategy, SWOT and Corporate Finance Report Summary Bank Rossiya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Martin Resource Management Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Martin Resource Management Corp (MRMC) is an oil and gas service provider that markets and distributes fuel oil, asphalt, sulfuric acid, diesel fuel and naphthenic lubricants. The company provides transportation, marketing, terminalling and logistics management services for hydrocarbon produ …
  • Burwill Holdings Limited:企業のM&A・事業提携・投資動向
    Burwill Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Burwill Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Stilo International Plc (STL):企業の財務・戦略的SWOT分析
    Summary Stilo International plc (Stilo) operates as a technology company that offers cloud content solutions. The company’s products include developer tools, XML cloud conversion and SME authoring. It offers digital content and publishes information to multiple channels such as print, web, CD-ROM, s …
  • Aratana Therapeutics Inc (PETX):製薬・医療:M&Aディール及び事業提携情報
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • MYnd Analytics Inc (MYND):製薬・医療:M&Aディール及び事業提携情報
    Summary MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychia …
  • Corbion NV (CRBN):企業の財務・戦略的SWOT分析
    Corbion NV (CRBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Trinity Industries, Inc (TRN):電力:M&Aディール及び事業提携情報
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • Shanghai Pharmaceutical Co Ltd (601607):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • Arlington Asset Investment Corp (AI):企業の財務・戦略的SWOT分析
    Summary Arlington Asset Investment Corp (AAIC) is an investment firm that offers asset management and investment services. The firm acquires and holds mortgage-related assets. It acquires residential mortgage-backed securities issued by the US government agencies. AAIC also acquires mortgage-backed …
  • AmWINS Group Inc:企業のM&A・事業提携・投資動向
    AmWINS Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AmWINS Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • GS Yuasa Corporation (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corporation (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • LG Electronics Inc (066570):企業の財務・戦略的SWOT分析
    LG Electronics Inc (066570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆